October 17, 2026 12:50 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'How dare Elon Musk?' Owaisi defends Modi after billionaire's 'real boss' jibe at Ambani | 'B****y S***': IAS officer's abuse of female colleague during virtual J&K meeting sparks row | Aamir Khan’s nephew Imran Khan asked to leave India by Oct 28 after joining anti-CEC protest | ‘Their crime? Demanding justice’: Rahul Gandhi slams 4 AM detention of Ankita Bhandari’s parents | ‘Bangladesh showed us the way’: Neha Bora’s remarks spark BJP attack on Rahul Gandhi | Chingrighata flyover skid scare: Bikes fall, anti-skid blocks installed overnight as Bengal Minister Agnimitra Paul faces criticism | Meerut blue drum murder case: Muskaan, her lover get death sentence | 'Rise up, young patriots!': American singer Mary Millben alleges CJP gets US funding, urges peaceful protests | 'Won't go unchallenged': Muhammad Yunus heckling in New York triggers legal action warning | flydubai cockpit attack probe widens: Two Maldivian pilots detained in UAE over links to Omani co-pilot
Coronavirus Vaccine

Covid vaccine approval likely soon : DCGI

| @indiablooms | Dec 31, 2020, at 11:29 pm

New Delhi/IBNS: The coronavirus vaccines awaiting approval can be cleared soon, India's drug control authority said Thursday.

Drugs Controller General Dr VG Somani said today in a webinar that probably there will be "a happy new year with something in hand".

Somani's assurance came a day ahead of the crucial meeting of the expert panel to authorise emergency use of vaccines made by Serum Institute of India, Bharat Biotech and Pfizer, said reports.

The Centre had formed an expert panel to examine the application of emergency vaccine approval by the drug companies.

Serum Institute is manufacturing Covishield developed by Oxford University and Pharma major AstraZeneca while Bharat Biotech is manufacturing Covaxin partnering with Indian Council of Medical Research (ICMR).

Reports said both the firms have made the presentations before the panel but Pfizer is yet to present the data.

Once cleared by the expert panel, the applications will go to the DCGI for approval. An NDTV report said that officials have said the Oxford vaccine is likely to get approval first.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.